WebFLUARIX QUADRIVALENT prior influenza vaccine, the decision to give safely and effectively. See full prescribing information for FLUARIX QUADRIVALENT. ... -----INDICATIONS AND USAGE----- FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses … WebJul 22, 2024 · Indications and Usage for Afluria. Afluria ® is an inactivated influenza virus vaccine indicated for active immunization of persons ages 6 months and older against influenza disease caused by influenza virus …
GSK begins shipping another record supply of influenza …
WebJan 12, 2024 · FLUARIX ® QUADRIVALENT was first approved in 2012 in the US for the prevention of influenza disease in people 3 years of age and older. It is also approved in more than 30 other countries worldwide. WebFeb 15, 2024 · The expanded indication was based on a Phase III pivotal efficacy study of Fluarix Tetra in children six months through 35 months of age and on two supportive studies. About Seasonal Influenza Influenza is an acute, highly contagious, respiratory disease caused by influenza viruses, mainly spread through respiratory droplets. graphic design sinhala fonts
To report SUSPECTED ADVERSE REACTIONS, contact …
WebOct 15, 2024 · Age indication Hemagglutinin or virus count per vaccine virus (per dose) Route of administration Mercury from thimerosal (mcg per 0.5 mL) ... Fluarix Quadrivalent: 0.5-mL prefilled syringe: Web1 INDICATIONS AND USAGE 3 FLUARIX® QUADRIVALENT is indicated for active immunization for the prevention of 4 disease caused by influenza A subtype viruses and type B viruses contained in the vaccine [see 5 Description (11)]. FLUARIX QUADRIVALENT is approved for use in persons 3 years of age 6 WebThe purpose of this submission is to extend the indication down to 3 years of age. Fluarix-US-005. This is a multi-center (~25 centers in US), single-blind, active-controlled study to demonstrate ... graphic designs international contract